The Current Landscape of Antibody-based Therapies in Solid Malignancies

Over the past three decades, monoclonal antibodies (mAbs) have revolutionized the landscape of cancer therapy. Still, this benefit remains restricted to a small proportion of patients due to moderate response rates and resistance emergence. The field has started to embrace better mAb-based formats w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Shah, Ashu, Rauth, Sanchita, Aithal, Abhijit, Kaur, Sukhwinder, Ganguly, Koelina, Orzechowski, Catherine, Varshney, Grish C, Jain, Maneesh, Batra, Surinder K
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738893/
https://ncbi.nlm.nih.gov/pubmed/33391547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.52614
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados